Parathyroid symptom assessment study
Part of Hormones & metabolism clinical trials.
This study looks at how your parathyroid condition affects your symptoms and quality of life. You will fill out a simple questionnaire about your health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have primary hyperparathyroidism (PHPT) — a condition where your parathyroid glands make too much hormone, causing high calcium levels.
- You may have had PHPT surgery or are planning to have it.
- You are not pregnant.
- You are not under guardianship or curatorship.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with primary hyperparathyroidism (a hormone-related condition that affects calcium levels). It aims to better understand the condition and who it affects, which may help improve care over time.
This study looks at how chronic hypoparathyroidism affects daily life and well-being. It may help understand the condition better and improve support for patients.
This study follows adults with hypoparathyroidism to better understand what symptoms and lab levels change over time. It may help doctors plan future treatments by learning the natural course of the condition, even if you already take standard medicines.
This study looks at how patients' quality of life changed after they had parathyroidectomy (surgery to remove parathyroid glands) for secondary hyperparathyroidism related to end-stage kidney disease. The goal is to understand the benefits of this surgery for future patients.
This is an observational study that follows people who have or may develop parathyroid-related conditions. The goal is to better understand how these problems change over time and what patterns show up, which can help improve future care.
This is a registry (data collection) study that gathers information about people diagnosed with chronic hypoparathyroidism in France. It helps researchers better understand how common it is and what it looks like in real life.
Hear when a new Quality of Life in Primary Hyperparathyroidism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.